Detailed Narrative
Q2 & H1 FY26 Financial Performance Overview
Godavari Biorefineries showed clear signs of recovery in Q2 FY26, with revenue from operations growing 34% year-on-year to INR430.8 crores. The EBITDA shortfall significantly narrowed to INR4.4 crores from a loss of INR31.5 crores in Q2 FY25. Gross margin expanded by 4.5% to 21% in Q2 FY26. For H1 FY26, revenue grew 14% to INR964 crores, and EBITDA turned positive at INR2.1 crores from a loss of INR41 crores in H1 FY25, with gross margin expanding 5% to 20%.
Strategic Focus on High-Value Bio-based Chemicals
The company's strategy to prioritize higher-value bio-based specialty chemicals contributed significantly to profitability. The biobased chemicals portfolio saw a 60% jump in segment EBITDA in Q2 FY26, driven by better realization and an increased share of specialty crops. Management noted that the ratio of bio-based specialty chemicals to non-specialty chemicals (ethyl acetate) improved to 63% from 57%, directly translating into better EBITDA.
Ethanol Business Recovery and Future Outlook
The ethanol segment returned to positive EBITDA of INR4.7 crores in Q2 FY26, compared to a loss of INR2.9 crores a year earlier, due to improved blending economics and stronger off-take. The company is on track to commission its 200-kilo litres per day fungible grain-based distillery in Q4 FY26, which is expected to produce about 60 million liters annually, aiming to mitigate feedstock and policy risks.
Government Policy and Sugar Industry Dynamics
The outlook for the 2025-2026 sugar season is positive, with above-average monsoons and improved cane yields. The government's proposal to allow exports of 1.5 million tons of sugar and remove a 50% export duty on molasses is expected to positively impact mills' revenues and support industry competitiveness. However, the lack of revision in ethanol procurement prices by oil marketing companies remains a concern.
Sustainability Initiatives: CO2 to Dimethyl Ether (DME) Project
Godavari Biorefineries launched a pilot CO2 to DME project in collaboration with ICT Mumbai. This breakthrough technology converts industrial CO2 emissions into dimethyl ether, a low-emission, eco-friendly energy carrier that can replace LPG and diesel. The project is currently in the pilot phase after successful lab work, with implications for decarbonization and clean energy solutions, especially for fermentation facilities and power plants.
Drug Discovery and Bioplastics
The company is progressing with its drug discovery efforts, having completed safety trials for an anti-cancer molecule. An application for preliminary efficacy trials is being prepared, and a U.S.-facing step-down subsidiary is planned to find out-licensing partners. The preliminary efficacy trials are expected to take two years, with out-licensing targeted within two to three years. While exploring a range of bio-based chemicals, bioplastics are not a current focus.
Jivana Brand Expansion
The Jivana brand, initiated to ensure better price resilience and market acceptance for sugar and associated products, has grown significantly. Revenue from the Jivana brand increased from INR28 crores a few years ago to INR108 crores in FY25, with H1 FY26 revenue at INR65 crores. The company plans to expand the brand's offerings to include other food items like brown sugar, jaggery, and turmeric through its wide retail presence.
Exceptional Items and Cost Management
The company reported an exceptional item📎 of INR7.7 crores in Q2 FY26 related to a retrospective revision of harvesting and transport charges for cane supplies. This was done to match neighboring mills in Karnataka and secure cane, and management views this as a one-off📎 event rather than a signal of higher ongoing operating costs. The company remains focused on cost optimization and strategic investments to improve cash flow.